摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-2-((S)-2,6-Diamino-hexanoylamino)-propionic acid | 16806-35-2

中文名称
——
中文别名
——
英文名称
(S)-2-((S)-2,6-Diamino-hexanoylamino)-propionic acid
英文别名
Lysinoalanine;Lys-Ala;LysAla;KA;N-L-lysyl-L-alanine;N-L-Lysyl-L-alanin;L-lysyl-L-alanine;(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]propanoic acid
(S)-2-((S)-2,6-Diamino-hexanoylamino)-propionic acid化学式
CAS
16806-35-2;17043-71-9;59154-65-3;71227-34-4
化学式
C9H19N3O3
mdl
——
分子量
217.268
InChiKey
QOOWRKBDDXQRHC-BQBZGAKWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    494.4±45.0 °C(Predicted)
  • 密度:
    1.169±0.06 g/cm3(Predicted)
  • 物理描述:
    Solid

计算性质

  • 辛醇/水分配系数(LogP):
    -3.5
  • 重原子数:
    15
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.78
  • 拓扑面积:
    118
  • 氢给体数:
    4
  • 氢受体数:
    5

SDS

SDS:5f6e1415989277d2e7aca626c815b30e
查看

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] BENZYL SUBSTITUTED INDAZOLES AS BUB1 INHIBITORS<br/>[FR] INDAZOLES À SUBSTITUANTS BENZYLE UTILISÉS COMME INHIBITEURS DE BUB1
    申请人:BAYER PHARMA AG
    公开号:WO2016042084A1
    公开(公告)日:2016-03-24
    Compounds of formula (I) as defined herein and their use as pharmaceuticals.
    本公式(I)所定义的化合物及其作为药物的用途。
  • Presence of a dipeptidyl aminopeptidase III in Saccharomyces cerevisiae.
    作者:Yasuhiro WATANABE、Yuka KUMAGAI、Yukio FUJIMOTO
    DOI:10.1248/cpb.38.246
    日期:——
    The soluble fraction of a cell extract of Saccharomyces cerevisiae was found to contain hydrolytic activity toward arginyl-arginyl-β-naphthylamide (Arg-Arg-βNA). Most of the contaminating Arg-βNA hydrolysis activity was removed by diethylaminoethyl (DEAE)-cellulose column chromatography and the enzyme was partially purified. It is very similar in various properties to mammalian dipeptidyl aminopeptidase III (DAP III), although it differs slightly in some respects.
    研究发现,酿酒酵母细胞提取物的可溶性部分含有对精氨酰-精氨酰-β-萘甲酰胺(Arg-Arg-βNA)的水解活性。通过二乙氨基乙基(DEAE)-纤维素柱层析法去除了大部分污染性 Arg-βNA 水解活性,并部分纯化了该酶。它的各种特性与哺乳动物的二肽基氨基肽酶 III(DAP III)非常相似,但在某些方面略有不同。
  • Electron-Capture and -Transfer Dissociation of Peptides Tagged with Tunable Fixed-Charge Groups: Structures and Dissociation Energetics
    作者:Thomas W. Chung、Christopher L. Moss、Magdalena Zimnicka、Richard S. Johnson、Robert L. Moritz、František Tureček
    DOI:10.1007/s13361-010-0012-9
    日期:2011.1.1
    Pyridiniummethylcarbonyl moieties that were previously designed on the basis of electronic structure analysis are now utilized as fixed-charge tags with tunable electronic properties to be used for N-terminal peptide derivatization and sequencing by electron-transfer dissociation. Dipeptides AK and KA were derivatized at the peptide N-terminus with 4-dimethylaminopyridinium-N-acetyl (DMAP-ac) and pyridinium-N-acetyl (pyrid-ac) tags of increasing intrinsic recombination energies. Upon the capture of a free electron or electron transfer from fluoranthene anions, (DMAP-ac-AK+H)2+, (DMAP-ac-KA+H)2+, (pyrid-ac-AK+H)2+ and (pyrid-ac-KA+H)2+ ions, as well as underivatized (AK+2H)2+, completely dissociated. The fixed-charge tags steered the dissociation upon electron transfer to form abundant backbone N–Cα bond cleavages, whereas the underivatized peptide mainly underwent H-atom and side-chain losses. Precursor ion structures for the tagged peptides were analyzed by an exhaustive conformational search combined with B3LYP/6-31+G(d,p) geometry optimization and single-point energy calculations in order to select the global energy minima. Structures, relative energies, transition states, ion–molecule complexes, and dissociation products were identified for several charge-reduced species from the tagged peptides. The electronic properties of the charge tags and their interactions with the peptide moieties are discussed. Electrospray ionization and electron-transfer dissociation of larger peptides are illustrated with a DMAP-tagged pentapeptide.
    以前根据电子结构分析设计的吡啶甲基羰基现在被用作具有可调电子特性的固定电荷标签,通过电子转移解离用于肽 N 端衍生和测序。二肽 AK 和 KA 在肽 N 端用 4-二甲基氨基吡啶鎓-N-乙酰基(DMAP-ac)和吡啶鎓-N-乙酰基(pyrid-ac)标签衍生,标签的内在重组能不断增加。从荧蒽阴离子捕获自由电子或进行电子转移时,(DMAP-ac-AK+H)2+、(DMAP-ac-KA+H)2+、(吡啶-ac-AK+H)2+ 和 (吡啶-ac-KA+H)2+ 离子以及未充分活化的 (AK+2H)2+ 完全解离。固定电荷标签在电子转移时引导解离,形成大量的骨架 N-Cα 键裂解,而未充分活化的多肽主要发生 H 原子和侧链损失。通过详尽的构象搜索、B3LYP/6-31+G(d,p) 几何优化和单点能量计算,分析了标记肽的前体离子结构,以选择全局能量最小值。从标记肽中确定了几种电荷还原物种的结构、相对能量、过渡态、离子-分子复合物和解离产物。本文讨论了电荷标签的电子特性及其与肽分子的相互作用。以 DMAP 标记的五胜肽为例,说明了较大肽的电喷雾电离和电子转移解离。
  • Iodine-containing peptides
    申请人:Schering Aktiengesellschaft
    公开号:US05756066A1
    公开(公告)日:1998-05-26
    Iodine-containing peptides of general formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, a, m and q have the meanings indicated in the description, agents containing these compounds, the use of compounds as contrast media as well as processes for their production are described.
    本发明涉及一般式I的含碘肽,其中R1,R2,R3,R4,a,m和q具有说明书中所示的含义,含有这些化合物的试剂,将化合物用作对比剂的用途以及它们的生产过程。
  • Process for preparing a B30-threonine insulin
    申请人:SHIONOGI & CO., LTD.
    公开号:EP0017938A1
    公开(公告)日:1980-10-29
    A process for preparing a B30-threonine-insulin is described which comprises reacting a des-B30-insulin with an excess amount of a threonine derivative represented by the formulawherein Thr is L-threonine residue, R1 is hydrogen or a hydroxy-protecting group; and R2 is a carboxyl-protecting group, in the presence of an enzyme specifically acting on the basic-amino-acid carbonyl in peptide linkages.
    描述了一种制备 B30-苏氨酸胰岛素的工艺,该工艺包括在一种专门作用于肽键中碱性氨基酸羰基的酶存在的情况下,将去 B30-胰岛素与过量的苏氨酸衍生物进行反应,其中 Thr 为 L-苏氨酸残基,R1 为氢或羟基保护基团,R2 为羧基保护基团。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物